META vs MRK: Which Is the Better Buy?
Side-by-side comparison of Meta Platforms, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Meta Platforms, Inc. · Communication Services
$611.40
+12.9% upside to fair value
High Conviction
Grade A-
VS
Merck & Co., Inc. · Healthcare
$121.42
-2.9% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
META has more upside to fair value
(+12.9%).
MRK trades at a lower forward P/E
(14.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
META |
MRK |
| Current Price |
$611.40 |
$121.42 |
| Fair Value Estimate |
$690.00 |
$118.00 |
| Upside to Fair Value |
+12.9%
|
-2.9%
|
| Market Cap |
$1,541.3B |
$300.2B |
| Forward P/E |
23.0x
|
14.0x
|
| EV / EBITDA |
18.0x
|
11.8x
|
| Price / Sales |
7.7x
|
4.1x
|
| Price / FCF |
33.4x
|
21.4x
|
| Revenue Growth YoY |
+22.2%
|
+1.3%
|
| Gross Margin |
82.0%
|
81.5%
|
| Operating Margin |
41.4%
|
41.2%
|
| Return on Equity |
30.6%
|
34.7%
|
| Dividend Yield |
0.4% |
3.1% |
| FCF Yield |
3.0%
|
4.7%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Meta Platforms operates the world's largest social media ecosystem (Facebook, Instagram, WhatsApp, Threads) reaching 3.3B+ daily users, generating $201B in revenue predominantly from digital advertising. The company's 82% gross margins and AI-powered ad targeting create an extraordinarily profitable core business. Trading at its 5-year P/E low of 25.5x despite 22% revenue growth, META is cheap on…
Merck is a top-5 global pharmaceutical company generating $65B in annual revenue with 81.5% gross margins and 28% net margins. Keytruda, the world's best-selling drug at $31.7B (49% of pharma revenue), faces patent expiry in 2028. Merck is aggressively building replacements through M&A and pipeline launches: Winrevair ($1.4B year one), Capvaxive ($759M), and the $6.7B Terns acquisition for TERN-7…
Accumulation Zones
| Metric |
META |
MRK |
| Zone Low |
$520.00 |
$88.00 |
| Zone High |
$590.00 |
$100.00 |
| In Buy Zone? |
No
|
No
|